Featured Research

from universities, journals, and other organizations

Myc's Cancer-Causing Joy Ride More Reckless Than Previously Believed

Date:
October 12, 1999
Source:
University Of Rochester
Summary:
Many drivers feel the urge to floor the accelerator on a crisp sunny day when the highway ahead seems to stretch straight to eternity. But only the most foolish would cut the brake line while pushing the pedal to the metal. Yet one of the body's most potent cancer-causing genes does precisely that inside a cell, scientists at the University of Rochester Medical Center have found.

Many drivers feel the urge to floor the accelerator on a crisp sunny day when the highway ahead seems to stretch straight to eternity. But only the most foolish would cut the brake line while pushing the pedal to the metal.

Related Articles


Yet one of the body's most potent cancer-causing genes does precisely that inside a cell, scientists at the University of Rochester Medical Center have found. The result of the unfettered molecular joy ride is, oftentimes, cancer. Details of the research are in the October issue of the Journal of the European Molecular Biology Organization (EMBO).

Scientists have long recognized that the protein produced by a gene known as myc spurs a cell to grow. Just like pushing the accelerator makes a car move forward, producing more myc makes a cell grow and divide. Too much myc spells an invitation to cancer, where cells grow uncontrollably and invade other tissues.

Now scientists have found that myc is even more powerful than they anticipated: The gene also has a role in disabling the molecular signals, the "brakes," that cells rely on to slow growth. When myc is out of control, not only is the accelerator floored but the brakes are out. It's no wonder that the gene plays a role in many human cancers, including those in the lung, colon, breast, bladder, and brain.

"Myc is central to our cells' ability to grow, divide, and even die when they should," says Hartmut Land, Ph.D., director of the University's Center for Cancer Biology and lead investigator of the EMBO study. "Basically, myc is like the starter of an engine; it's responsible for making the whole cell go. It's a very potent gene, but one that's been slow to yield its secrets. Myc has been a conundrum."

Land's team showed that myc controls another protein, cyclin D, known to play a big role in making cells grow; the EMBO paper marks the first time scientists have identified the "brains" behind cyclin D's actions. Land's team also found that cyclin D can not only accelerate growth, which has been known, but also knock out the proteins that a cell normally uses to put the brakes on growth, a surprising finding.

While Land says it's too early to know the implications of the work for cancer treatment, the findings mark another step in scientists' journey to unravel the amazing cell-signaling network that underlies our body's ability to produce cancer cells. That process is the focus of more than 100 scientists just joining the Center for Cancer Biology, a new effort begun by the University this year to study how faulty cell signals can conspire to cause cancer.

"Unraveling cell signaling is more or less like looking at a chess board and trying to figure out how the game is being played. What are the important rules? Who are the key players?" asks Land, who is the Robert and Dorothy Markin Professor of Cancer Biology.

"We're scratching the surface of a complexity that five years ago, nobody even dreamed about. The full texture of the biochemical circuitry of cells is just beginning to emerge, and that's exciting. Information like this helps us to understand how to manipulate cancer cells and ultimately should help us treat cancer in new and unexpected ways."

Land was one of the first to realize the immensity of the signaling network inside a cell, discovering in the early 1980s that multiple genetic changes are necessary for a cell to become cancerous. Much of his work has been done at the Imperial Cancer Research Fund in London, where Land did research before coming to the University this year.

Also contributing to the project research were Soo-Hyun Kim and Beatrice Griffiths of the Imperial Cancer Research Fund; Ignacio Perez-Roger, now at the Instituto de Biomedicina in Valencia, Spain; and Andreas Sewing, now with Smithkline Beecham Pharmaceuticals. The work was funded by the Imperial Cancer Research Fund and the European Community.


Story Source:

The above story is based on materials provided by University Of Rochester. Note: Materials may be edited for content and length.


Cite This Page:

University Of Rochester. "Myc's Cancer-Causing Joy Ride More Reckless Than Previously Believed." ScienceDaily. ScienceDaily, 12 October 1999. <www.sciencedaily.com/releases/1999/10/991012075440.htm>.
University Of Rochester. (1999, October 12). Myc's Cancer-Causing Joy Ride More Reckless Than Previously Believed. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/1999/10/991012075440.htm
University Of Rochester. "Myc's Cancer-Causing Joy Ride More Reckless Than Previously Believed." ScienceDaily. www.sciencedaily.com/releases/1999/10/991012075440.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) — The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins